Skip to content
Screener

Medtronic MDT Asset write-downs

Asset write-downs at other companies

Stryker logo
StrykerSYK
$0-100%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$109.98B-3.9%
Enterprise value$137.24B-3.3%
P/E22.9×-1.7×
P/S-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354
(in millions)Fiscal Year / 2026Fiscal Year / 2025Fiscal Year / 2024
Provision for credit losses13612390
Deferred income taxes51(316)(508)
Stock-based compensation457429393
Asset impairments and related inventory write-downs371
Other, net314310573
Change in operating assets and liabilities, net of acquisitions and divestitures:
Accounts receivable, net(200)(433)(391)
Inventories(404)(292)(139)

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's asset write-downs?
Medtronic (MDT) reported asset write-downs of $0 in Q1 2026.
What is the long-term trend for Medtronic's asset write-downs?
Over 4 years (2022 to 2026), Medtronic's asset write-downs has grown at a -100.0% compound annual growth rate (CAGR), from $515M to $0.

Ask your AI about Medtronic's asset write-downs.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude